ECRG4 expression was associated with better survival in esophageal [6] and prostate [10] carcinomas, and with inhibition of cell proliferation and migration in esophageal cancer [7]-[9], colorectal cancer and glioma [9], [11]. The gene discussed is ECRG4; the disease is central nervous system cancer.